Source Market Watch Biogen Inc. said Wednesday that a late-stage trial of a drug to treat of secondary progressive multiple sclerosis was unsuccessful. The trial of Natalizumab found that the drug was “well-tolerated” by patients but did not meet its primary and secondary endpoints. “While we’re disappointed with these results, we believe this research will… Read more »
Posts By: Sue
Study on Biotin for Secondary and Primary Progressive Forms of Multiple Sclerosis
Dr. Daniel Kantor talks about the MD1003 Trial analysis on Biotin for Secondary and Primary Progressive Multiple Sclerosis. Watch here.
Age UK Oxfordshire Exercise Classes
Lots of exercise classes, take a look! Age UK Oxfordshire Exercise Classes
Mobile nail technician
Didcot based mobile nail technician, available to come to your home: Susan Luker – Nailicious. Specialises in Gelish, Artistic gloss, Smart Gel Polish manicures with Gel Polish, Manicures with ordinary polish, mobile: 07748630273.
Books wanted
The book club has raided £54.65 since it has been running. If you have any recent novels that you can donate to the centre for the club please do.
Relapsing Remitting Multiple Sclerosis
My name is Virginie Louvel and I am a Senior Research Executive at Opinion Health, a London based market research agency. We are inviting a select number of people who have been diagnosed with Relapsing Remitting Multiple Sclerosis and are currently receiving a disease modifying therapy (DMT) to take part in a national wide project… Read more »
A new focus on brain health
Source MS Trust ECTRIMS is the European Committe for Treatment and Research in Multiple Sclerosis. Every year they hold the world’s largest conference on MS research and this year’s event is taking place this week in Barcelona. Amy Bowen, our Director of Service Development, reports on what is widely expected to be the most significant… Read more »
New global report on early treatment launched.
Source MS Society A new international report on early treatment has been launched today. Brain health: time matters in multiple sclerosis, was written by a global expert group led by UK neurologist Professor Gavin Giovannoni. This follows the MS Society’s consensus paper on early treatment released on Wednesday 30 September. Read on.
Flu jab study
Source MS Trust: As well as the symptoms caused by ‘flu’, the fever associated with the infection can lead to a worsening of multiple sclerosis symptoms for those people with MS who are adversely affected by heat. NICE guidelines state that people with MS should be offered immunisation against influenza as infections may be associated… Read more »
Quiz night
Two weeks until the quiz night, only 6 teams entered, if less than 8 I will have to pull it. Please please let me know if you can join in a Centre team or if you can get a team together yourself. Many thanks
